Revenio Group Corporation | Press Release | February 05, 2026 at 10:30:00 EET
Revenio has appointed Jussi Nevanlinna as Global Marketing Director of its subsidiary Icare. The position is new. Nevanlinna will assume his role on April 1, 2026, and report to Revenio CEO Jouni Toijala.
Nevalinna joins Icare from Finnish Innovation Fund Sitra. He has previously held senior marketing leadership roles at Qualcomm, Microsoft, and Nokia.
“During the current strategy period, Revenio has transformed from a supplier of eye health devices into a provider of comprehensive eye care solutions. At the core of our work are innovative and user-friendly products and AI-based software solutions that streamline patients’ clinical care pathways while strengthening the customer experience and global awareness of the iCare brand. Jussi’s extensive experience in global business, together with his strong expertise in combining product management and product marketing, provides excellent support for the execution of our strategy and enables a stronger role for marketing in supporting the next phase of growth. I am very pleased to warmly welcome Jussi to the Revenio and Icare team”, says CEO Jouni Toijala.
Further information
CEO Jouni Toijala, tel. +358 50 484 0085
jouni.toijala@revenio.fi
Distribution
Key media
www.reveniogroup.fi/en
Revenio Group in brief
Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand.
In 2024, the Group’s net sales totaled EUR 103.5 million, with an operating profit of EUR 25.0 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.
